X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-02-18 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.02 | +500,000 | 2,383,500 | +27% | +$10,000 | ||||||
2022-08-18 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.02 | +500,000 | 1,883,500 | +36% | +$10,000 | ||||||
2023-03-27 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.02 | +8,700 | 883,500 | +1% | +$191 | ||||||
2023-03-03 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +3,840 | 874,800 | 0% | +$134 | ||||||
2023-02-08 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.04 | +4,960 | 870,960 | +1% | +$174 | ||||||
2023-01-30 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.03 | +9,000 | 866,000 | +1% | +$225 | ||||||
2023-01-25 | CTTH | Ctt Pharmaceutical Holdings, Inc. | CEO | P - Purchase | $0.02 | +61,695 | 857,000 | +8% | +$1,481 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |